The Effects of Lung-Moistening Herbal Medicines on Bleomycin-Induced Pulmonary Fibrosis Mouse Model

被引:4
|
作者
Ahn, Junmo [1 ]
Joo, Hyejin [2 ]
Park, Jihye [3 ]
Park, Jae-Woo [1 ]
Kim, Kwan-Il [1 ]
Jung, Hee-Jae [1 ]
Bu, Youngmin [1 ]
Lee, Beom-Joon [1 ]
机构
[1] Kyung Hee Univ, Coll Korean Med, Seoul 02447, South Korea
[2] Kyung Hee Univ, Grad Sch, Coll Sci Korean Med, Seoul 02447, South Korea
[3] Kyung Hee Univ, Grad Sch, Dept Biomed Sci & Technol, Seoul 02447, South Korea
基金
新加坡国家研究基金会;
关键词
pulmonary fibrosis; bleomycin; herbal medicine; broncho alveolar lavage fluid; inflammation; DIAGNOSIS;
D O I
10.3390/pr8010102
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
In traditional medicine, lung-moistening herbal medicines (LMHM) are regarded as a major option for treating symptoms of pulmonary fibrosis (PF) including dry cough and dyspnea. As PF agents are being applied to the development of lung cancer agents, PF and lung cancer are reported to have high pathological and pharmacological relationships. This study was proposed to identify candidates for the treatment of PF via investigating the effect of LMHM on PF mouse model. PF was induced by intratracheal instillation of bleomycin. Six water extracts of LMHM such as Farfarae Flos (FAF), Trichosanthis Semen (TRS), Lilii Bulbus (LIB), Adenophorae Radix (ADR), Asteris Radix (ASR), and Scrophulariae Radix (SCR) were prepared and administered (300 mg/kg) orally for 10 days after induction. The changes in body weight, histopathology, and immune cell of bronchoalveolar lavage fluid (BALF) were investigated. Among those, LIB and ADR significantly decreased the deposition of collagen and septal thickness of alveolar and terminal bronchiole. Moreover, SCR, TRS, LIB, and ADR decreased total cells, macrophages, and lymphocytes in BALF. Taken together, ADR and LIB could be the candidates to reduce PF. Further studies on their effects at different doses and analysis of their underlying molecular mechanisms are needed.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Antifibrotic Effects of Lilii Bulbus Extract in a Mouse Model of Bleomycin-induced Pulmonary Fibrosis
    Chiang, Shuen-Cheng
    Park, Jihye
    Bae, Jinhyun
    Joo, Hyejin
    Lee, Donghyun
    Kim, Kwan-Il
    Ko, Seok-Jae
    Park, Jae-Woo
    Bu, Youngmin
    Lee, Beom-Joon
    PHARMACOGNOSY MAGAZINE, 2021, 17 (76) : 679 - 683
  • [2] Pirfenidone activates cannabinoid receptor 2 in a mouse model of bleomycin-induced pulmonary fibrosis
    Liu, Jinhong
    Shi, Guiling
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (06) : 4241 - 4248
  • [3] Aucubin Alleviates Bleomycin-Induced Pulmonary Fibrosis in a Mouse Model
    Zhou, Yong
    Li, Ping
    Duan, Jia-Xi
    Liu, Tian
    Guan, Xin-Xin
    Mei, Wen-Xiu
    Liu, Yong-Ping
    Sun, Guo-Ying
    Wan, Li
    Zhong, Wen-Jing
    Ouyang, Dong-Sheng
    Guan, Cha-Xiang
    INFLAMMATION, 2017, 40 (06) : 2062 - 2073
  • [4] Aucubin Alleviates Bleomycin-Induced Pulmonary Fibrosis in a Mouse Model
    Yong Zhou
    Ping Li
    Jia-Xi Duan
    Tian Liu
    Xin-Xin Guan
    Wen-Xiu Mei
    Yong-Ping Liu
    Guo-Ying Sun
    Li Wan
    Wen-Jing Zhong
    Dong-Sheng Ouyang
    Cha-Xiang Guan
    Inflammation, 2017, 40 : 2062 - 2073
  • [5] Adenophorae Radix Reduces Fibrosis in a Bleomycin-Induced Pulmonary Fibrosis Mouse Model
    Kim, Eui-Joong
    Park, Jiwon
    Yu, Chang-Hwan
    Park, Jae-Woo
    Kim, Kwan-Il
    Jung, Hee-Jae
    Kim, Jang-Hoon
    Bu, Youngmin
    Lee, Beom-Joon
    NATURAL PRODUCT COMMUNICATIONS, 2024, 19 (01)
  • [6] Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib
    Chilakapati, Shanmuga Reddy
    Serasanambati, Mamatha
    Vissavajjhala, Prabhakar
    Kanala, Jagadeeshwara Reddy
    Chilakapati, Damodar Reddy
    EXPERIMENTAL LUNG RESEARCH, 2015, 41 (04) : 173 - 188
  • [7] Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis
    Liu, Qi
    Jiang, Jun-xia
    Liu, Ya-nan
    Ge, Ling-tian
    Guan, Yan
    Zhao, Wei
    Jia, Yong-liang
    Dong, Xin-wei
    Sun, Yun
    Xie, Qiang-min
    TOXICOLOGY LETTERS, 2017, 273 : 1 - 9
  • [8] The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis Cilengitide and Bleomycin-Induced Pulmonary Fibrosis
    Ritzenthaler, Jeffrey D.
    Zhang, Michael
    Torres-Gonzalez, Edilson
    Roman, Jesse
    LUNG, 2020, 198 (06) : 947 - 955
  • [9] Effects of aging on accompanying intermittent hypoxia in a bleomycin-induced pulmonary fibrosis mouse model
    Lee, Heayon
    Kim, In Kyoung
    Im, Jeonghyeon
    Jin, Bae Suk
    Kim, Hwan Hee
    Kim, Sei Won
    Yeo, Chang Dong
    Lee, Sang Haak
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (06) : 934 - 944
  • [10] Small airway remodeling in a sheep model of bleomycin-induced pulmonary fibrosis
    Derseh, Habtamu B.
    Dewage, Sasika N. Vithana
    Perera, Udari E.
    Koumoundouros, Emmanuel
    Pagel, Charles N.
    Organ, Louise
    Snibson, Ken J.
    EXPERIMENTAL LUNG RESEARCH, 2020, 46 (10) : 409 - 419